Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Genitourinary 1

Conditions

Prostatic Neoplasms 9Pancreatic Neoplasms 2Breast Neoplasms 2Vitamin D Deficiency 1Thyroid Nodule 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Obesity 1Leukemia 1Hypocalcemia 1Cholangiocarcinoma 1Castration-resistant Prostate Cancer 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1

Interventions

Cyclophosphamide 7fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 6Whole-Body Irradiation 5Tacrolimus 4Mycophenolic Acid 4Melphalan 4Busulfan 4Sulindac 3Methotrexate 3Biopsy 3Antilymphocyte Serum 3fludarabine 2Sirolimus 2Patient Reported Outcome Measures 2Mesna 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Gene Expression Profiling 2Etoposide 2Epoetin Alfa 2Eflornithine 2Cyclosporine 2Cetuximab 2Celecoxib 2vandetanib 1tanespimycin 1sintilimab 1perillyl alcohol 1antitumor A 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Precancerous Conditions × Calcitriol × Clear all
NCT00118066 2015-05-27

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Rutgers, The State University of New Jersey

Phase 2 Terminated
12 enrolled
GenitourinaryOther neoplasm

Precancerous Conditions, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡